首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal STMN1 Antibody

  • 中文名: STMN1抗体
  • 别    名: Lag; SMN; OP18; PP17; PP19; PR22; LAP18; C1orf215
货号: IPDX10991
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/1000-1/2000 Human,Mouse,Rat

产品详情

AliasesLag; SMN; OP18; PP17; PP19; PR22; LAP18; C1orf215
WB Predicted band size17 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human STMN1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是3篇关于STMN1抗体的代表性文献示例(注:文献信息为模拟概括,仅供参考):

---

1. **文献名称**: *Stathmin 1 overexpression correlates with poor prognosis in gastric cancer and promotes metastasis through EMT*

**作者**: Li X, et al.

**摘要**: 研究通过免疫组化(使用STMN1抗体)发现STMN1在胃癌组织中高表达,且与患者生存率低相关。体外实验表明STMN1通过诱导上皮-间质转化(EMT)促进肿瘤侵袭。

2. **文献名称**: *Targeting STMN1 with a therapeutic antibody inhibits ovarian cancer progression*

**作者**: Wang Y, et al.

**摘要**: 研究开发了一种靶向STMN1的单克隆抗体,证实其可抑制卵巢癌细胞增殖并增强紫杉醇化疗敏感性,动物模型中显著减少肿瘤转移。

3. **文献名称**: *STMN1 knockdown reverses chemoresistance in colorectal cancer via microtubule stabilization*

**作者**: Chen H, et al.

**摘要**: 通过Western blot(使用STMN1抗体)和功能实验,发现抑制STMN1可稳定微管结构,逆转结直肠癌细胞对5-FU的耐药性,提示其作为治疗靶点的潜力。

---

如需真实文献,建议通过PubMed或Google Scholar检索关键词(如"STMN1 antibody" "Stathmin 1 therapeutic"),并筛选近5年高被引论文。

背景信息

STMN1 (Stathmin 1), also known as oncoprotein 18 (Op18), is a cytosolic phosphoprotein encoded by the STMN1 gene. It plays a critical role in regulating microtubule dynamics by promoting depolymerization or preventing polymerization of tubulin, thereby influencing cell cycle progression, mitosis, and intracellular transport. Overexpression of STMN1 is associated with enhanced cell proliferation, migration, and malignancy in various cancers, including breast, ovarian, and hepatocellular carcinomas. Its expression is tightly regulated by phosphorylation, which modulates its microtubule-destabilizing activity in response to cellular signals.

STMN1 antibodies are essential tools for studying its expression, localization, and post-translational modifications in both physiological and pathological contexts. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to assess STMN1 levels in cancer tissues, where it serves as a potential prognostic biomarker. Researchers also utilize STMN1 antibodies to investigate mechanisms of drug resistance, as its dysregulation is linked to chemotherapeutic failure. Additionally, studies explore STMN1's role in neurological disorders due to its expression in neuronal tissues. The development of specific STMN1 antibodies has advanced research into targeting this protein for therapeutic interventions, such as microtubule-stabilizing agents in cancer treatment.

客户数据及评论

折叠内容

大包装询价

×